Statins lower stroke severity, improve recovery

February 26, 2009

Mayo Clinic researchers have shown that patients who were taking statins before a stroke experienced better outcomes and recovery than patients who weren't on the drug — even when their cholesterol levels were ideal. The finding is reported in the current issue of the Journal of Stroke and Cerebrovascular Diseases.

"We were trying to determine if the daily use of statins had more of an impact on stroke patients than simply lowering their "bad" (low-density lipid) cholesterol," explains lead researcher Latha Stead, M.D. "We already knew statin use improved outcomes in general, so we focused on the patients who had optimal LDL levels and found it still had quite significant value."

Statins or reductase inhibitors are enzymes that are widely used to improve cardiovascular health and, more recently, for certain vascular conditions in the brain. One use has been to lower the level of LDL which can contribute to arterial blockages.

Previous researchers had shown a lower death rate and improved function in strokes when people had used statins. The Mayo team found that statin used in this cohort also decreased the severity of the strokes and significantly improved overall outcomes. The researchers say this shows benefits far beyond lowering lipid levels. Researchers think the specific benefits may include plaque stabilization and improved cell function in vascular walls, as well as anti-inflammatory and antioxidant factors. More research is needed to pinpoint the specific benefits.

Researchers identified 508 patients who were diagnosed with acute ischemic stroke in the emergency department during the 22 months from March 2004 to December 2005. Among that number, 207 had their lipid levels measured within 15 days either side of the stroke incident — and had LDL levels at or below 100 mg/dL, which is considered optimal for healthy individuals. Roughly half the cohort of 207 had been taking statins. Researchers also adjusted for age, gender and stroke severity.

Source: Mayo Clinic


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


February 26, 2009 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

What a grind: Bruxism at night likely a sign of stress by day

Medicine & Health / Health

created 29 minutes ago | popularity not rated yet | comments 0

You can practically track Steve Barkley's stress by the level of activity in his temporomandibular joint, or TMJ, the hinge joint that connects the lower jaw to the temporal bone of the skull and helps one chew, talk and ...


Overeating can set stage for obesity, researchers say

Medicine & Health / Health

created 5 hours ago | popularity not rated yet | comments 0

It doesn't seem like a fair fight. In one corner loomed the Thanksgiving table, groaning with poultry, pie and mashed potatoes.


eye

Over-the-counter eye drops raise concern over antibiotic resistance

Medicine & Health / Medications

created 12 hours ago | popularity 3.5 / 5 (2) | comments 1

(PhysOrg.com) -- The use of antibiotic eye drops for conjunctivitis has increased by almost half since they became available over the counter at chemists in 2005, data obtained by Oxford University researchers ...


New tools for prediction of disease progression in acute childhood leukemia

Medicine & Health / Cancer

created 6 hours ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Researchers at Uppsala University and University Children’s Hospital in Uppsala have devised powerful new tools for typing cells from children with acute lymphatic leukemia and for prediction of how children ...


Nuclear science to fight sleeping sickness

Medicine & Health / Diseases

created 9 hours ago | popularity not rated yet | comments 0

The International Atomic Energy Agency on Friday announced an agreement to help African nations battle the tsetse fly, the main carrier of parasites that causes sleeping sickness with its bites.